Drug & intervention

axitinib

RxCUI 1242999

Clinical trials12
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

12 shown
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 MutationsNCT05904730 · 2023-07-11
COMPLETED
A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)NCT05017012 · 2021-09-21
COMPLETED
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)NCT04585815 · 2020-11-10
TERMINATED
Study of PF-07265807 in Participants With Metastatic Solid Tumors.NCT04458259 · 2020-09-24
TERMINATED
A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell CarcinomaNCT04522323 · 2020-08-05
ACTIVE_NOT_RECRUITING
Survival Prolongation by Rationale Innovative GenomicsNCT03386929 · 2017-11-29
TERMINATED
Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node MetastasisNCT01409200 · 2012-03-26
COMPLETED
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose AxitinibNCT01540526 · 2012-03-01
COMPLETED
Axitinib Before Surgery in Treating Patients With High-Risk Prostate CancerNCT01385059 · 2011-10-28
COMPLETED
A Study of Axitinib in Advanced Carcinoid TumorsNCT01435122 · 2011-10-25
COMPLETED
Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung CancerNCT00768755 · 2009-01-01
COMPLETED
Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung CancerNCT00094094 · 2005-02-01
COMPLETED

Conditions being studied

Carcinoma, Non-Small Cell Lung2Advanced or Metastatic Solid Tumors1Advanced Renal Cell Carcinoma1BRCA Mutation1Breast Cancer1Breast Neoplasms1Carcinoid Tumor1Carcinoma, Non-Small-Cell Lung1HER-2 Protein Overexpression1HER2-negative Breast Cancer1HER2-positive Breast Cancer1Lung Neoplasms1Metastatic Castrate-resistant Prostate Cancer1Metastatic Malignant Neoplasm in Lymph Node1Neoplasm Metastasis1Non-small Cell Lung Cancer Metastatic1Non-small Cell Lung Cancer Stage IIIB1Ovarian Cancer1Ovarian Neoplasms1Prostate Ductal Adenocarcinoma1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.